ClearPoint Neuro, Inc.
ClearPoint Neuro, Inc.
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Financial Statements
Values in Millions ($) | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Financial statements beyond 3 years are for subscribers only. Unlock 17+ years of income statements, balance sheets, and cash flow statements Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||||||||
Assets Current | |||||||||||||||||
Cash And Cash Equivalents At Carrying Value | 29 | 36 | 46 | 38 | 42 | 12 | 20 | 22 | 33 | 35 | 23 | 24 | |||||
Short Term Investments | - | - | - | - | - | - | - | - | - | - | 0 | 0 | |||||
Accounts Receivable Net Current | 8 | 9 | 7 | 4 | 4 | 4 | 5 | 4 | 3 | 3 | 3 | 2 | |||||
Inventory Net | 9 | 9 | 8 | 7 | 6 | 7 | 7 | 7 | 8 | 8 | 8 | 9 | |||||
Prepaid Expense And Other Assets Current | 2 | 2 | 3 | 3 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | |||||
Assets Current | 49 | 55 | 64 | 51 | 54 | 24 | 33 | 34 | 47 | 48 | 36 | 37 | |||||
Property Plant And Equipment Net | 3 | 3 | 3 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | |||||
Operating Lease Right Of Use Asset | 13 | 13 | 8 | 6 | 6 | 3 | 3 | 3 | 3 | 3 | 4 | 4 | |||||
Inventory Noncurrent | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Indefinite Lived Contractual Rights | - | - | - | - | - | 0 | 0 | 1 | 1 | 1 | 1 | 1 | |||||
Goodwill | 7 | 7 | 7 | - | - | - | 0 | - | - | - | - | - | |||||
Intangible Assets Net Excluding Goodwill | 13 | 13 | 14 | - | - | - | 0 | - | - | - | - | - | |||||
Other Assets Noncurrent | 2 | 2 | 2 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | |||||
Assets | 87 | 93 | 98 | 60 | 63 | 30 | 39 | 40 | 53 | 54 | 43 | 44 | |||||
Liabilities And Stockhold… | |||||||||||||||||
Liabilities Current | |||||||||||||||||
Accounts Payable Current | 2 | 2 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | |||||
Employee Related Liabilities Current | 4 | 3 | 4 | 4 | 3 | 2 | 5 | 4 | 3 | 2 | 3 | 2 | |||||
Other Accrued Liabilities Current | 2 | 2 | 3 | 2 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | |||||
Operating Lease Liability Current | 0 | 0 | 1 | 0 | 0 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | |||||
Contract With Customer Liability Current | 2 | 2 | 2 | 2 | 1 | 2 | 2 | - | - | - | - | - | |||||
Deferred Revenue Current | - | - | - | - | - | - | 2 | 1 | 1 | 1 | 3 | 1 | |||||
Convertible Notes Payable Current | - | - | - | - | - | - | - | - | 10 | 10 | - | - | |||||
Liabilities Current | 10 | 9 | 11 | 8 | 7 | 7 | 10 | 8 | 17 | 15 | 7 | 6 | |||||
Operating Lease Liability Noncurrent | 14 | 14 | 8 | 6 | 6 | 3 | 3 | 3 | 3 | 3 | 4 | 4 | |||||
Deferred Revenue Noncurrent | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 1 | 1 | |||||
Contract With Customer Liability Noncurrent | 1 | 1 | 1 | 1 | 1 | 0 | 0 | - | - | - | - | - | |||||
Long Term Notes Payable | 50 | 50 | 49 | 29 | 29 | - | 0 | - | - | - | - | - | |||||
Secured Long Term Debt | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 10 | 10 | |||||
Deferred Income Tax Liabilities Net | 0 | 0 | 0 | - | - | - | 0 | - | - | - | - | - | |||||
Other Liabilities Noncurrent | 1 | 1 | 0 | 0 | - | - | 0 | - | - | - | - | - | |||||
Liabilities | 76 | 75 | 70 | 44 | 43 | 10 | 14 | 11 | 20 | 19 | 21 | 20 | |||||
Stockholders Equity | |||||||||||||||||
Preferred Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Additional Paid In Capital Common Stock | 246 | 239 | 239 | 225 | 223 | 217 | 216 | 215 | 213 | 211 | 193 | 192 | |||||
Common Stock Shares Subscriptions | 3 | 6 | 6 | - | - | - | 0 | - | - | - | - | - | |||||
Retained Earnings Accumulated Deficit | -238 | -226 | -217 | -209 | -203 | -197 | -191 | -186 | -181 | -177 | -172 | -168 | |||||
Stockholders Equity | 11 | 19 | 28 | 16 | 20 | 20 | 25 | 29 | 32 | 35 | 21 | 24 | |||||
Liabilities And Stockholders Equity | 87 | 93 | 98 | 60 | 63 | 30 | 39 | 40 | 53 | 54 | 43 | 44 | |||||
Preferred Stock Par Or Stated Value Per Share | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |||||
Preferred Stock Shares Authorized | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 25 | |||||
Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Common Stock Par Or Stated Value Per Share | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |||||
Common Stock Shares Authorized | 90 | 90 | 90 | 90 | 90 | 90 | 90 | 90 | 90 | 90 | 90 | 90 | |||||
Common Stock Shares Issued | 31 | 30 | 29 | 28 | 28 | 28 | 28 | 28 | 28 | 27 | 25 | 25 | |||||
Shares Outstanding | 31 | 30 | 29 | 28 | 28 | 28 | 28 | 28 | 28 | 27 | 25 | 25 | |||||
Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables
Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables
Custom Table
Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals
Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals
Interactive Financial Visualizations
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Earnings Market Reaction
| Fiscal Year | Q1 1 Month | Q1 2 Month | Q1 3 Month | Q2 1 Month | Q2 2 Month | Q2 3 Month | Q3 1 Month | Q3 2 Month | Q3 3 Month | Q4 1 Month | Q4 2 Month | Q4 3 Month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 5.74% | 53.57% | 22.56% | - | - | - | - | - | - | - | - | - |
| 2025 | -1.90% | -17.61% | -29.58% | 4.84% | 159.77% | 120.30% | -20.68% | -23.09% | -13.99% | -22.22% | 14.87% | 15.50% |
| 2024 | -7.81% | -8.49% | 25.47% | 101.55% | 73.76% | 102.48% | -7.82% | 17.36% | 33.01% | -22.30% | -28.92% | -23.46% |
| 2023 | - | - | - | -10.31% | -21.72% | -19.06% | 9.78% | 25.28% | 28.78% | 6.28% | -2.98% | -10.25% |
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial | ||||||||||||
Subscribe to unlock 17+ years of financial data and 90+ calculated metrics
Subscribe to unlock 17+ years of data and 90+ calculated metrics
Performance and Valuation Metrics
Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.
Metrics | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Metric history beyond 3 years is for subscribers only. Unlock 17+ years of history across 90+ calculated metrics Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Liquidity Ratios | |||||||||||||||||
| Current Ratio | 4.74 | 5.79 | 5.91 | 6.37 | 7.30 | 3.53 | 3.22 | 4.54 | 2.79 | 3.14 | 4.87 | 6.68 | |||||
| Quick Ratio | 3.66 | 4.67 | 4.87 | 5.24 | 6.19 | 2.34 | 2.40 | 3.37 | 2.18 | 2.50 | 3.55 | 4.79 | |||||
| Working Capital | 38.62M | 45.40M | 52.84M | 43.28M | 46.59M | 17.35M | 23.01M | 26.78M | 29.86M | 32.41M | 28.74M | 31.72M | |||||
Leverage & Debt | |||||||||||||||||
| Debt to Equity | 7.05 | 3.96 | 2.49 | 2.80 | 2.18 | 0.50 | 0.54 | 0.39 | 0.64 | 0.55 | 1.01 | 0.82 | |||||
| Interest Coverage TTM | -9.30 | -11.56 | -22.82 | -17.71 | -23.80 | -23.77 | -22.63 | -25.51 | -29.53 | -54.70 | -58.15 | -58.60 | |||||
| Debt Ratio | 0.88 | 0.80 | 0.71 | 0.74 | 0.69 | 0.34 | 0.35 | 0.28 | 0.39 | 0.36 | 0.50 | 0.45 | |||||
Efficiency & Turnover | |||||||||||||||||
| Asset Turnover TTM | 0.57 | 0.66 | 0.54 | 0.68 | 0.58 | 0.77 | 0.77 | 0.72 | 0.56 | 0.50 | 0.49 | 0.44 | |||||
| Days Sales Outstanding TTM | 54.63 | 55.33 | 55.59 | 41.86 | 42.02 | 34.89 | 46.07 | 37.78 | 40.79 | 36.20 | 44.77 | 47.71 | |||||
| Receivables Turnover TTM | 6.68 | 6.60 | 6.57 | 8.72 | 8.69 | 10.46 | 7.92 | 9.66 | 8.95 | 10.08 | 8.15 | 7.65 | |||||
Per Share Metrics | |||||||||||||||||
| Diluted EPS TTM | -1.15 | -0.98 | -0.90 | -0.81 | -0.79 | -0.75 | -0.70 | -0.66 | -0.65 | -0.81 | -0.90 | -0.89 | |||||
| Free Cash Flow Per Share TTM | -1.04 | -0.90 | -0.86 | -0.49 | -0.41 | -0.42 | -0.34 | -0.32 | -0.35 | -0.49 | -0.59 | -0.66 | |||||
| Dividend Per Share TTM | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
Margin Metrics | |||||||||||||||||
| Gross Profit Margin TTM | 62.61% | 62.33% | 61.38% | 61.31% | 60.42% | 61.20% | 60.92% | 60.38% | 59.85% | 57.10% | 56.83% | 58.10% | |||||
| Operating Profit Margin TTM | -73.42% | -65.20% | -65.36% | -66.28% | -67.39% | -67.26% | -62.87% | -61.80% | -66.06% | -80.08% | -93.70% | -99.51% | |||||
| Net Profit Margin TTM | -81.76% | -71.57% | -69.08% | -67.40% | -66.15% | -64.51% | -60.25% | -59.64% | -64.06% | -78.84% | -92.21% | -97.92% | |||||
Growth Metrics | |||||||||||||||||
| Net Revenue Growth (1Y) | 25.86% | 25.99% | 17.78% | 12.83% | 19.68% | 23.22% | 31.04% | 36.34% | 29.33% | 24.86% | 16.56% | 13.53% | |||||
| Net Income Growth (1Y) | 55.54% | 39.78% | 35.03% | 27.51% | 23.58% | 0.81% | -14.37% | -16.97% | -13.69% | 14.05% | 34.40% | 34.92% | |||||
| EPS Growth (1Y) | 45.70% | 31.13% | 28.89% | 23.76% | 20.13% | -7.43% | -22.05% | -25.88% | -22.75% | 10.16% | 32.09% | 34.19% | |||||
Valuation Metrics | |||||||||||||||||
| P/E TTM | -15.57 | -9.25 | -15.17 | -26.77 | -15.18 | -15.85 | -21.98 | -17.04 | -8.23 | -8.39 | -7.56 | -5.65 | |||||
| P/B TTM | 49.94 | 14.27 | 13.82 | 39.02 | 17.09 | 16.49 | 16.37 | 10.67 | 4.61 | 5.00 | 7.89 | 5.12 | |||||
| P/S TTM | 12.73 | 6.62 | 10.48 | 18.04 | 10.04 | 10.22 | 13.24 | 10.16 | 5.27 | 6.62 | 6.97 | 5.53 | |||||
| Market Cap | 538.17M | 268.88M | 387.35M | 619.44M | 337.40M | 329.58M | 415.69M | 309.30M | 148.05M | 173.07M | 167.07M | 123.40M | |||||
| Enterprise Value | 558.12M | 282.00M | 389.46M | 610.42M | 324.53M | 317.19M | 395.58M | 287.73M | 125.19M | 147.69M | 153.88M | 108.99M | |||||
Calculated Values | |||||||||||||||||
| Free Cash Flow TTM | -31.29M | -26.70M | -24.45M | -13.82M | -11.72M | -11.74M | -9.23M | -8.91M | -9.73M | -12.46M | -14.44M | -16.35M | |||||
| Net Debt | 19.94M | 13.13M | 2.10M | -9.02M | -12.88M | -12.39M | -20.10M | -21.57M | -22.87M | -25.39M | -13.19M | -14.41M | |||||
Per-Share and Margin | |||||||||||||||||
| EPS TTM | |||||||||||||||||
| Adjusted EPS TTM | |||||||||||||||||
| Cash Flow Per Share TTM | |||||||||||||||||
| Pretax Margin TTM | |||||||||||||||||
| Stock Comp to Revenue TTM | |||||||||||||||||
Turnover Ratios and Averages | |||||||||||||||||
| Average Assets | |||||||||||||||||
| Average Equity | |||||||||||||||||
| Average Inventory | |||||||||||||||||
| Average Receivables | |||||||||||||||||
| Average Accounts Payables | |||||||||||||||||
| Inventory Turnover TTM | |||||||||||||||||
| Payables Turnover TTM | |||||||||||||||||
| Days Inventory Outstanding TTM | |||||||||||||||||
| Days Payables Outstanding TTM | |||||||||||||||||
| Cash Conversion Cycle TTM | |||||||||||||||||
| Working Capital to Revenue | |||||||||||||||||
| Deferred Revenue to Revenue | |||||||||||||||||
Growth Rates | |||||||||||||||||
| Total Assets Growth (1Y) | |||||||||||||||||
| Total Assets Growth (3Y) | |||||||||||||||||
| Total Assets Growth (5Y) | |||||||||||||||||
| Dividends Paid Growth (1Y) | |||||||||||||||||
| Dividends Paid Growth (3Y) | |||||||||||||||||
| Dividends Paid Growth (5Y) | |||||||||||||||||
| EPS Growth (3Y) | |||||||||||||||||
| EPS Growth (5Y) | |||||||||||||||||
| Net Income Growth (3Y) | |||||||||||||||||
| Net Income Growth (5Y) | |||||||||||||||||
| Net Profit Margin Growth (1Y) | |||||||||||||||||
| Net Profit Margin Growth (3Y) | |||||||||||||||||
| Net Profit Margin Growth (5Y) | |||||||||||||||||
| Net Revenue Growth (3Y) | |||||||||||||||||
| Net Revenue Growth (5Y) | |||||||||||||||||
| Deferred Revenue Growth (1Y) | |||||||||||||||||
| Retained Earnings Growth (1Y) | |||||||||||||||||
Credit, Liquidity, Returns, Payout | |||||||||||||||||
| Cash Ratio | |||||||||||||||||
| Net Working Capital | |||||||||||||||||
| Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to Equity | |||||||||||||||||
| Altman A | |||||||||||||||||
| Altman B | |||||||||||||||||
| Altman C | |||||||||||||||||
| Altman D | |||||||||||||||||
| Altman E | |||||||||||||||||
| Altman Z-Score | |||||||||||||||||
| ROA TTM | |||||||||||||||||
| ROE TTM | |||||||||||||||||
| NOPAT TTM | |||||||||||||||||
| ROIC TTM | |||||||||||||||||
| Effective Tax Rate TTM | |||||||||||||||||
| Payout Ratio TTM | |||||||||||||||||
| Dilution Ratio | |||||||||||||||||
| Retained Earnings to Equity | |||||||||||||||||
| Treasury Stock to Equity | |||||||||||||||||
| Treasury Stock Change (1Y) | |||||||||||||||||
| Accrued to Current Liabilities | |||||||||||||||||
| NCAV | |||||||||||||||||
| NCAV Per Share TTM | |||||||||||||||||
Valuation Ratios | |||||||||||||||||
| P/CF TTM | |||||||||||||||||
| Dividend Yield TTM | |||||||||||||||||
| Free Cash Flow Yield TTM | |||||||||||||||||
| EV EBITDA TTM | |||||||||||||||||
| EV EBIT TTM | |||||||||||||||||
| Stock Compensation TTM | |||||||||||||||||
| Adjusted Net Income TTM | |||||||||||||||||
| Billings TTM | |||||||||||||||||
| Total Debt | |||||||||||||||||
| Invested Capital | |||||||||||||||||
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Insider Transactions
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Institutional Ownership
ClearPoint Neuro, Inc. (CLPT) — SEC Financial Statements & Analysis
ClearPoint Neuro, Inc. (CLPT) is a surgical & medical instruments & apparatus company, incorporated in DE. ClearPoint Neuro, Inc. trades on Nasdaq as: CLPT. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), ClearPoint Neuro, Inc. reported a 25.86% year-over-year revenue growth, a Gross Profit Margin of 62.61% (TTM), a Debt-to-Equity ratio of 7.05x, a Price-to-Sales (P/S) ratio of 12.73x (TTM), a Price-to-Book (P/B) ratio of 49.94x (TTM), at a market cap of $538.17M. Figures below are sourced from SEC EDGAR, as-filed.
- Net Revenue TTM Growth 1Y
- 25.86%
- Gross Profit Margin TTM
- 62.61%
- Debt To Equity
- 7.05x
- P/S TTM
- 12.73x
- P/B TTM
- 49.94x
- Market Cap
- $538.17M
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is ClearPoint Neuro, Inc. in?
ClearPoint Neuro, Inc. (CLPT) operates in the Surgical & Medical Instruments & Apparatus industry.
What is CLPT's market cap?
ClearPoint Neuro, Inc. (CLPT) has a market capitalization of $538.17M as of 2026-06-30.
What exchange does CLPT trade on?
ClearPoint Neuro, Inc. (CLPT) trades on the Nasdaq.
Where is ClearPoint Neuro, Inc. incorporated?
ClearPoint Neuro, Inc. is incorporated in DE.